It seems as though a new weight loss medication comes out in the news every few months. However, occasionally one emerges, and Retatrutide is one of these.
Retatrutide works on three hormones, compared to existing drugs which primarily affect one or two of these hormones. It works on the GLP1, GIP and glucagon receptors which help to decrease your appetite, as well as boost your energy output. Basically, it’s not only about reducing food intake; it could also be about burning more energy.
Phase 3 clinical trials have been recently successful. Over 80 weeks, the participants who had obesity achieved an average loss of over 20% of their body weight. Scientists also found that levels of blood sugar were kept better, and several heart health indicators were better.
With that being said, it is crucial to not have unrealistic expectations. Common side effects of retatrutide are similar to those of other similar medications and include nausea, vomiting and diarrhea. It is still being studied for its long term safety, such as heart and blood vessel problems, before it’s available widely.
Obesity is more complex than just 'eating too much. It’s related to hormones, genes, metabolism and the brain. That is why newer drugs are going more than just the willpower approach and focusing on the biology of weight regulation.
Currently not available on pharmacy shelves yet, retatrutide has the potential to be another significant breakthrough in the realm of obesity and obesity-related conditions if continued studies prove safe and effective. The drug’s developer will try to get regulatory clearance in the near future.
A new discovery every now and then will remind us how quickly medicine is moving on , but not in giant strides.
What are your thoughts on weight loss medications?
MBH/PS